InvestorsHub Logo

JPetroInc

08/25/14 10:02 AM

#108101 RE: docoroc2 #108100

"Between the warrants and the Lincoln Park Capital equity funding facility, the Company has approximately $25 million in additional funding available, which the Company believes would fund operations until at least deep into 2016, however there is no assurance that the warrants will be exercised or that we will be able to fully draw from the Lincoln Park facility."



Reason for AS Increase Vote:

"As of this date, however, the Company requires additional authorized shares to assure the capital markets and investors that the Company has adequate common shares available to complete M&A activity if an attractive opportunity presents itself, raise additional funds if needed, and offer adequate equity compensation to enable recruitment of the best talent the Company will be seeking to bring on full-time as employees. The Company has been advised by various stakeholders in the larger capital markets community that it is best for the Company to achieve an appropriate capital structure while still on the OTC Markets so that the cap structure risk is mitigated once on a national exchange. In addition to an increase in the number of our authorized shares, we are seeking shareholder approval for various other matters that will better position the Company for the up-list to a national exchange."





- See more at: http://www.thechairmansblog.com/amarantus-bioscience/gerald-commissiong/preparing-amarantus-list-2h-14-capital-markets-strategy/#sthash.d3PDiNjj.dpuf

brharris

08/25/14 10:56 AM

#108102 RE: docoroc2 #108100

IMO there is more going on here and its not that simple. However I am keeping a watchful eye on things. It doesn't appear that the market is scared. I will listen to the market as we await further news from GC and company.

Maybe you made the smart move but my money is still on AMBS.

christjamin

08/25/14 11:47 AM

#108103 RE: docoroc2 #108100

I think, you make a good point. AGain it is all guessing game. I am long and strong AMBS though. Nobody knows how things will turn out so, you might have been smart as you might have screwed yourself. Either way, so long as you are comfortable with your action, be happy you made that decision. However, I would recommend you avoid sitting on this board and saying nasty staff just to bring the pps down..We are hopeful and we hold onto our shares..

macnqueso

08/25/14 8:35 PM

#108108 RE: docoroc2 #108100

an excellent question... like you i find myself unable to formulate an acceptable answer... btw... whatever happened to the IND for MANF? in the sector of pre-monetized biotechnology... clinical trials are the life blood of product development... the failure of the company to advance MANF in clinical trials is, to me, deeply disturbing...

dshade

08/26/14 8:58 AM

#108118 RE: docoroc2 #108100

I believe the pressure to uplist and access to BIG funding will encourage them to R/S by about 20-1. Normally I would not be a supporter, but, in this case it may speed up their development and exposure.